JPS5913707A - Cosmetic composition containing adzuki saponin - Google Patents

Cosmetic composition containing adzuki saponin

Info

Publication number
JPS5913707A
JPS5913707A JP12245082A JP12245082A JPS5913707A JP S5913707 A JPS5913707 A JP S5913707A JP 12245082 A JP12245082 A JP 12245082A JP 12245082 A JP12245082 A JP 12245082A JP S5913707 A JPS5913707 A JP S5913707A
Authority
JP
Japan
Prior art keywords
skin
adzuki
saponin
water
butanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP12245082A
Other languages
Japanese (ja)
Inventor
Shigeru Yuchi
有地 滋
Akio Fujikawa
藤川 明男
Yoshihiro Uchida
義弘 内田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TAIYO RIKAGAKU KENKYUSHO KK
Original Assignee
TAIYO RIKAGAKU KENKYUSHO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TAIYO RIKAGAKU KENKYUSHO KK filed Critical TAIYO RIKAGAKU KENKYUSHO KK
Priority to JP12245082A priority Critical patent/JPS5913707A/en
Publication of JPS5913707A publication Critical patent/JPS5913707A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)

Abstract

PURPOSE:To provide a cosmetic containing adzuki saponin extracted from adzuki beans as an active component, and effective to reduce the amount of lipid peroxide on the skin, keep the skin healthy, and prevent and improve the chappy skin, spots and freckles, etc. CONSTITUTION:The objective cosmetic contains 0.01-1% of powdery adzuki saponin (90-98% purity) which is a mixture of the compounds of formula (when R<1> is beta-D-glucopyranosyl (1 2)-beta-D-glucuronopyranosyl, R<2>, R<3>, R<4> and R<6> are methyl and R<5> is OH, etc.) Adzuki saponin has the activity to reduce the amount of lipid peroxide on the skin remarkably, and is expected to have high safety to continuous use. It is used in the cosmetics such as milky lotion, cream, soap, skin powder, etc. Adzuki saponin can be prepared by defatting adzuki beans, extracting with a lower aliphatic alcohol, concentrating the extract, fractionating with water and n-butanol, and separating from the n-butanol layer.

Description

【発明の詳細な説明】 本発明はアズキザボニン含有化粧料組成物、さらに詳し
くは、皮表の過酸化脂質量を減少させて、皮膚の健常性
を保持する化粧料組成物に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a cosmetic composition containing azukizabonin, and more particularly to a cosmetic composition that reduces the amount of lipid peroxide on the skin surface and maintains the health of the skin.

皮膚の健常性を保つことは、「肌あれ」、「しみ」、「
そはかす」等の予防、改善において非常に重要なことで
あるが、近年、とくに女性において、皮膚、それも顔面
皮膚の健常性の低下が目立っている。これは食性活の変
遷や生活リズムの不規則化によるところが多いが、皮膚
における過酸化脂質量の増大がその一因と考えられる。
Maintaining healthy skin is important for preventing rough skin, age spots, and
This is extremely important in the prevention and improvement of skin problems such as ``scratches,'' but in recent years, there has been a noticeable decline in the health of the skin, especially facial skin, especially in women. This is mostly due to changes in dietary habits and irregular lifestyle rhythms, but one factor is thought to be an increase in the amount of lipid peroxide in the skin.

過酸化脂質は、主として、不飽和脂肪酸の自動酸化によ
って生成する脂肪酸の過酸化物で、その生成は内的な因
子と共に、紫外線、放射線、金属イオン等の外的因子に
より促進され、化粧才」による皮膚障害の一因としての
可能性もいわれており、皮膚の健常性に著しい悪影響を
及はすものである。
Lipid peroxide is mainly a fatty acid peroxide produced by autoxidation of unsaturated fatty acids, and its production is promoted by internal factors as well as external factors such as ultraviolet rays, radiation, and metal ions. It is also said that it may be a cause of skin disorders due to skin irritation, and it has a significant negative impact on the health of the skin.

事実、各種の顔面皮膚疾患と皮表過酸化脂質量lこ相関
性があり、過酸化脂質量の増加が表皮細胞の蛋白変性を
引起し、皮膚の炎症、色素沈着の主因となることが証明
されている。
In fact, there is a correlation between various facial skin diseases and the amount of lipid peroxide on the skin surface, and it has been proven that an increase in the amount of lipid peroxide causes protein degeneration of epidermal cells and is the main cause of skin inflammation and pigmentation. has been done.

本発明者らは、意外にも、アズキから抽出されるアズキ
ザボニンが皮表過酸化脂質量を著しく低下させ、化粧料
に配合して連用した場合に皮膚の健常性保持にきわめて
ずくれた効果を発揮することを見出し、本発明を完成す
るにいたった。
Surprisingly, the present inventors found that azukizabonin extracted from azuki beans significantly lowers the amount of lipid peroxide on the skin surface, and has an extremely deviant effect on maintaining skin health when combined with cosmetics and used continuously. The present invention was completed based on this discovery.

すなわち、本発明は、有効成分として、アズキサボニン
を配合してなる化粧料組成物を提供するものである。ア
ズキザボニンは常時食用に供されるアズキ由来のもので
あり、連用(こおいても安全性は高いものと考えられ、
本発明の化粧料組成物を連用することにより、皮膚の健
常性が保持され、その結果、「肌あれ」、「しみ」、「
そはかず」等の予防、改善にすぐれた効果が得られる。
That is, the present invention provides a cosmetic composition containing adzuki sabonin as an active ingredient. Azukizabonin is derived from the azuki bean, which is constantly eaten, and is considered to be highly safe even when used repeatedly.
By repeatedly using the cosmetic composition of the present invention, the health of the skin is maintained, and as a result, "rough skin", "spots", "
Excellent effects can be obtained in the prevention and improvement of conditions such as "Soakakazu".

本発明の化粧料組成物の有効成分として用いるアズキザ
ボニンは、アズキおよびアズキ同属植物・例えば、ツル
アズキ、ヤブッルアズキ、オオヤブツルアズキ、ヒメッ
ルアズキ、ブンドゥなとの種子から抽出分離し、溶剤で
精製するか、あるいは抽出液から樹脂吸着剤を用いて選
択的にサポニンを吸着させ、精製することによって得る
ことができる。
The azukizabonin used as an active ingredient in the cosmetic composition of the present invention is extracted and separated from the seeds of azuki bean and azuki congener plants such as azuki azuki, azuki azuki, azuki azuki, azuki azuki and a bundu, and purified with a solvent or extracted. It can be obtained by selectively adsorbing saponin from a liquid using a resin adsorbent and purifying it.

例えばアズキの種子を脱脂処理し、次いて低級脂肪族ア
ルコール又はその含水物で抽出し、抽出液を濃縮し、濃
縮エキヌを水とn−ブタノールで分配処理し、ブタノー
ル層を濃縮し、得られる粗サポニン成分を精製処理する
For example, azuki seeds are defatted, then extracted with a lower aliphatic alcohol or its water content, the extract is concentrated, the concentrated equine is distributed between water and n-butanol, and the butanol layer is concentrated. The crude saponin component is purified.

原料となるアズキの種子はなるべく種皮を除き粉砕する
。この粉砕物を脱脂処理する。その際、通常の肪溶性有
機溶媒、例えはエーテル、ヘキサン、ベンゼン、石油エ
ーテル、リフロイン、酢酸エチルなとが用いられるが、
好ましくは酢酸エチルである。
The raw material, the azuki seeds, is crushed with the seed coat removed as much as possible. This pulverized material is degreased. In this case, ordinary fat-soluble organic solvents such as ether, hexane, benzene, petroleum ether, reflourin, and ethyl acetate are used.
Ethyl acetate is preferred.

この脱脂物を低級脂肪族アルコール又はその含水物で抽
出処理する。この抽出は使用する溶媒が煮沸する程度に
加熱して行われる。低級脂肪族アルコールトシてはメタ
ノール、エタノール、プロハノール、ブタノール等が挙
りられるか、メタノールが最も好ましく次いてO〜60
係メタノール含有水が好ましい。この抽出処理は数回繰
り返すのが好ましく、−回の溶媒の使用量は」1記脱脂
物に対し2〜4倍CΦ量/重量)程度が好ましい。
This defatted product is extracted with a lower aliphatic alcohol or a water-containing product thereof. This extraction is carried out by heating the solvent to such an extent that it boils. Examples of lower aliphatic alcohols include methanol, ethanol, prohanol, butanol, etc., with methanol being the most preferred, followed by O~60
Methanol-containing water is preferred. It is preferable to repeat this extraction process several times, and the amount of solvent used in each step is preferably about 2 to 4 times the amount of CΦ/weight relative to the defatted product in step 1.

ついてこの抽出液をなるべく低温低圧で濃縮する。ある
程度濃縮が行なわれると褐色の沈澱物を生ずるので、こ
れを炉別するのが望ましい。そのp液をさらに濃縮して
エギヌ吉する。
The extract is then concentrated at as low temperature and pressure as possible. Since a brown precipitate is formed after a certain degree of concentration, it is desirable to separate the precipitate by furnace. The p-liquid is further concentrated and used as eginukichi.

この濃縮物(エキヌ状)を水とn−ブタノールで分配処
理する。この分配処理は(I)濃縮物を水とn−ブタノ
ールの混液の約2:1〜約1=2の重量比率のもの、好
ましくは約1:】の重量比率のもの表振盪するか(■)
濃縮物を水tこ懸濁し、n−ブタノールと共に振盪する
か、(m)a絹物を水飽和n−ブタノールに溶解後、水
を添加して振盪するか何れの方法によってもよい。目的
とするサポニン成分は、n−ブタノール層に移行される
。上記(11)の場合をさらに説明すれば、濃縮物をは
X同重量の水に懸濁し、これに約1.0〜2.0倍@C
重阻)のn−ブタノールを加えて振盪し、この処理を2
〜3回繰り返すことにより、目的とするアズキザボニン
成分をn−ブタノール層に移行させる。この際の温度は
常温で行われる。
This concentrate (equinu-like) is distributed between water and n-butanol. This distribution process involves (I) shaking the concentrate with a mixture of water and n-butanol in a weight ratio of about 2:1 to about 1=2, preferably in a weight ratio of about 1: )
Either method may be used, such as suspending the concentrate in water and shaking with n-butanol, or (m) dissolving the silk material in water-saturated n-butanol, adding water and shaking. The desired saponin component is transferred to the n-butanol layer. To further explain the case (11) above, the concentrate is suspended in water of the same weight as X, and about 1.0 to 2.0 times @C
Add n-butanol (heavily inhibited) and shake, and repeat this process for 2
By repeating this process ~3 times, the desired adzukizabonin component is transferred to the n-butanol layer. The temperature at this time is room temperature.

かくして得られるn−ブタノール層をなるべく低温低圧
で濃縮する。この濃縮は乾固するまで行うのが好ましい
。この濃縮物は粗サポニン成分からなるが、さらにこれ
は精製処理に付される。
The n-butanol layer thus obtained is concentrated at as low temperature and pressure as possible. This concentration is preferably carried out to dryness. This concentrate consists of crude saponin components, which are further subjected to purification treatments.

この精製処理の第一の方法は、サポニン成分に列し溶解
性の有機溶媒と非溶解性の有機溶媒とを組合わせて行わ
れる。該サポニン成分は水、メタノール、ジメチルヌル
ホキシト、ピリジン等に易溶性て、エーテル類、ヘキサ
ン、クロロホルム、アセトン、酢酸エチル等に不溶であ
り、これらを絹合わすことができるが、好ましい組合わ
せはメタノールとエチルエーテルである。すなわち、粗
サポニン成分を溶解性有機溶媒に溶解し、これを不溶解
性溶媒中に加えるか又はこれに不浴解性溶媒を加えるか
して行えばサポニン成分が精製されて析出する。この際
、活性炭処理ずれはより効果的である。
The first method of this purification treatment is carried out using a combination of an organic solvent that is soluble in the saponin component and an organic solvent that is not soluble in the saponin component. The saponin component is easily soluble in water, methanol, dimethylnulphoxide, pyridine, etc., but insoluble in ethers, hexane, chloroform, acetone, ethyl acetate, etc. These can be combined, but the preferred combination is They are methanol and ethyl ether. That is, the saponin component is purified and precipitated by dissolving the crude saponin component in a soluble organic solvent and adding it to an insoluble solvent or by adding a non-bath dissolvable solvent thereto. At this time, activated carbon treatment is more effective.

また第二の精製法として、上記粗サポニン成分を吸着性
樹脂と接触させて吸着させ、次いて溶離させてもよい。
As a second purification method, the crude saponin component may be brought into contact with an adsorbent resin to be adsorbed, and then eluted.

吸着性樹脂としては、巨大網状114造で多孔性の架橋
されたポリヌチレン系+11 Itsが好ましい。その
具体例とし、ではセルバクロムX A Dタイ7’−2
(100〜200μ、セルバクロム社製)、アンバーラ
イトXAI’)−2(ロームアンドハーヌ社製)等が挙
げられる。こトで使用する溶媒系としては、ます粗サポ
ニンを溶解するのに水又は30%以下の低級脂肪族アル
コール含有の水(好ましくは1.01メタ、ノール含有
水)を使用し、次に低級脂肪族アルコール又は約30%
以」二の低級脂肪族アルコール含有の水(好ましくは3
5〜99%メタノール)を用いて溶離させれはよい。
The adsorbent resin is preferably a giant reticular, porous, cross-linked polynutylene +11 Its. As a specific example, Selvachrome X A D tie 7'-2
(100 to 200μ, manufactured by Selvachrome), Amberlite XAI')-2 (manufactured by Rohm and Hahne), and the like. As the solvent system used here, water or water containing 30% or less of lower aliphatic alcohol (preferably water containing 1.01 meth, alcohol) is used to dissolve crude saponin, and then lower Fatty alcohol or about 30%
2 lower aliphatic alcohol-containing water (preferably 3
5-99% methanol).

また第三の精製法として、上記粗サポニン成分を遠心液
体クロマトグラフィ (例えば担体:KTゲル、富士ゲ
ル販売株式会社製:溶出溶媒:クロロホルム/メタノー
ル/水=10/3/1の下層二回転数:300RPM)
に伺して精製してもよい。
As a third purification method, the crude saponin component was purified by centrifugal liquid chromatography (for example, carrier: KT gel, manufactured by Fuji Gel Sales Co., Ltd.; elution solvent: chloroform/methanol/water = 10/3/1; lower layer rotation speed: 300RPM)
You can also visit and refine it.

さらに第−又は第二の精製法の手段に続いて第三の精製
法の手段を用いて精製してもよい。
Furthermore, following the means of the first or second purification method, the means of the third purification method may be used for purification.

このようにして得られたアズキサポニンは、実質的にザ
ボニン成分のみを含むものであって、そのまま本発明の
有効成分として使用できる。
The adzuki saponin thus obtained contains substantially only the zabonin component and can be used as it is as an active ingredient in the present invention.

得られたアズキザボニンは、水、アルコールに可溶な白
色粉末状で、シリカゲルプレート上でクロロホルム−メ
タノール−水(6:4:l”lを用いて薄層クロマトグ
ラフィーに付し、1係硫酸第二セリウムと、10%硫酸
の混液を噴霧して加熱すると、赤紫色を呈する6スポツ
トを与える。
The obtained azukizabonin was in the form of a white powder that was soluble in water and alcohol, and was subjected to thin layer chromatography on a silica gel plate using chloroform-methanol-water (6:4:1). When a mixture of dicerium and 10% sulfuric acid is sprayed and heated, it gives six reddish-purple spots.

〔式中k がβ−D−グルコピラノシル(1→2)−β
−Dグルクロノピラノ/ル基であるときは、R,R−R
とk がメチル基、艮 が水酸71 、 I丸、艮 と
Rがメチル基、k がオキ/メチル基、■(が水酸基;
k とk がメチル基、k がオキシメチル基、Rが水
素原子、Rがカルボキシル甚;又はK とk がメチル
基、R3がノチルオギシ基、k が水素原子、l(がβ
−1) −クルコピラノシル(1→6)−β−D −ク
ルコピラノンルーオキシ力ルボニル基、 艮 がβ−D−グルコピラノシル基であるときは、k 
と艮 がメチル基、艮 がカルボキンル基、k が水素
原子、k がβ−D−グルコピラノシル(1→6)−β
−D−グルコビラノンルーオキシカルボニル基、 Rカα−■、−ラムノビラノンル(1→2)−β−D−
グルコピラノンルC1→2)−β−D =グルクロノピ
ラノシル基であるときは、R+Rとk がメチル基、k
 がオキ/メチル基、k5が水酸基〕で示される化合物
の混合物であり、原料として用いたアズキにより若干差
異があるが」1記の精製により、純度90%以上で得ら
れる。
[In the formula, k is β-D-glucopyranosyl (1→2)-β
-D glucuronopyrano/ru group, R,R-R
and k are methyl groups, 艮 is hydroxyl71, I circle, 艮 and R are methyl groups, k is oxy/methyl group, ■(is hydroxyl group;
k and k are a methyl group, k is an oxymethyl group, R is a hydrogen atom, R is a carboxyl group; or K and k are a methyl group, R3 is a notyl group, k is a hydrogen atom, l (is β
-1) -Curcopyranosyl (1→6)-β-D-curcopyranone-oxycarbonyl group, when 艮 is a β-D-glucopyranosyl group, k
and 艮 are methyl groups, 艮 is carboquine groups, k is hydrogen atom, k is β-D-glucopyranosyl (1→6)-β
-D-glucobyranone-oxycarbonyl group, Rka α-■, -rhamnobyranone (1→2)-β-D-
When glucopyranone C1→2)-β-D = glucuronopyranosyl group, R+R and k are methyl groups, k
is an oxy/methyl group, and k5 is a hydroxyl group. Although there are slight differences depending on the azuki beans used as raw materials, it can be obtained with a purity of 90% or more by the purification described in 1.

本発明の化粧料組成物においては、かかる粉末状のアズ
キザボニンまたはそれを水、アルコール等の溶媒に溶解
もしくは分散させて有効成分として配合する。その配合
量は所望の剤形に応じて適宜選択できるが、通常、組成
物全量に対してアズキザボニン粉末o、ot−i%(純
度90〜98係として)程度配合することが効果上好ま
しい。
In the cosmetic composition of the present invention, the powdered azukizabonin or the same is dissolved or dispersed in a solvent such as water or alcohol, and is incorporated as an active ingredient. The amount to be blended can be appropriately selected depending on the desired dosage form, but it is usually preferable to blend adzukizabonin powder in an amount of about 0,000% (assuming a purity of 90 to 98) based on the total amount of the composition.

本発明の化粧料組成物は常法に従って乳液、ローション
、クリーム石鹸、てんか粉などの種々の剤形の化粧FI
 I医薬部外品としての薬用化粧料も含む)とすること
ができ、他の成分は特に限定するものではなく、通常こ
の種の化粧料に用いられる成分、例えは、流動パラフィ
ン、各種界面活性剤、ミツロウ、ヌクワラン、セタノー
ル、ステアリン酸、プロピレングリコール、防腐剤など
が使用できる。
The cosmetic composition of the present invention can be applied to cosmetic FIs in various dosage forms such as milky lotions, lotions, cream soaps, and soap powders in accordance with conventional methods.
(including medicinal cosmetics as quasi-drugs), other ingredients are not particularly limited, and ingredients normally used in this type of cosmetics, such as liquid paraffin and various surfactants. Agents, beeswax, Nuqualan, cetanol, stearic acid, propylene glycol, preservatives, etc. can be used.

つぎに参考例および実施例を挙げて本発明をさらに詳し
く説明する。
Next, the present invention will be explained in more detail with reference to reference examples and examples.

参考例1  (アズギサボニンノ製造)小豆(Vign
a angularis (Willd、 )Ohwi
 eLOhashi北海道産大納言)5kqを粉末とし
、ヘキサノ15 A’で1時間加熱抽出し脱脂を行ない
、その残留物についてメタノール15Jで加熱抽出する
。5時間還流した後屏過してメタノール抽出液を得、残
渣は新たにメタノール 151  を加え加熱抽出する
。同様の操作を計5回行い、得られたメタノール抽出液
を合し、減圧濃縮する。メタノール抽出液の濃縮過程に
おいてかっ色沈殿が生しるので、これを戸別し沈殿34
gを得る。炉液は減圧上溶媒留去しメタノールエキス9
6gを得る。このメタノールエキス961’を水100
献に懸濁させ、n−ブタノール(150mlX3)で抽
出する。n〜ブタノール移行部は減圧上溶媒留去し、n
−ブタノールエキス38gを得、また水移行部から同様
にして水工キス46gを得る。11−ブタノールエキス
38gを少量のメタノールに溶解し、多量のエチルエー
テル中に攪、拌しながら滴下する。生じる沈殿14gを
枦取した後、活性炭(特製白鷺、武田薬品工業株式会社
製)−セライ1−535 (和光純薬工業株式会社製)
カラムで脱色精製して白色粉末としてアズキザボニン1
0gを?4(、る。このアズキザボニンは以下の性質を
有ずろ。
Reference example 1 (Azugisaboninno production) Red beans (Vign
a angularis (Wild, ) Ohwi
Powder 5 kq of eLOhashi (Hokkaido-produced Dainagon), heat-extract with Hexano 15 A' for 1 hour to degrease, and heat-extract the residue with methanol 15 J. After refluxing for 5 hours, the mixture was filtered to obtain a methanol extract, and the residue was extracted with fresh methanol 151 by heating. The same operation is performed a total of 5 times, and the resulting methanol extracts are combined and concentrated under reduced pressure. During the concentration process of the methanol extract, a brown precipitate is formed, which is separated from each other and precipitated 34.
get g. The furnace liquid was distilled off under reduced pressure and the methanol extract 9
Obtain 6g. Add 961' of this methanol extract to 100' of water.
Suspend in solution and extract with n-butanol (150ml x 3). In the n~butanol transition section, the solvent was distilled off under reduced pressure, and n
- 38 g of butanol extract was obtained, and 46 g of suiko kiss was obtained in the same manner from the water transfer section. 38 g of 11-butanol extract was dissolved in a small amount of methanol and added dropwise to a large amount of ethyl ether with stirring. After collecting 14 g of the resulting precipitate, activated carbon (special Shirasagi, manufactured by Takeda Pharmaceutical Co., Ltd.) - Serai 1-535 (manufactured by Wako Pure Chemical Industries, Ltd.)
Azukizabonin 1 is decolorized and purified using a column as a white powder.
0g? 4. This Azukizabonin has the following properties.

a、  〔α’:12”4−11.1’(C= 1.0
、メタノール)のhか)+C,J褒を有する。
a, [α': 12"4-11.1' (C= 1.0
, methanol) has h or) + C, J reward.

1)、赤外線吸収スペクトJl、 (1<Rr、CTn
  )ハ3475 (ブロード、強)= 2930 C
強)、+609  (ブロード、強)、]100(ブロ
ード、強)に特有の吸収極太を有す。
1), infrared absorption spectrum Jl, (1<Rr, CTn
) C3475 (Broad, strong) = 2930 C
Strong), +609 (Broad, Strong), ]100 (Broad, Strong) has a unique absorption thickness.

C・ 白色粉末である。C. It is a white powder.

d−溶H性はジメチルヌルホキシト、ピリジンに易溶、
メタノール、水に可溶、アセトン、クロロホルム、エー
テル、ヘキサンに不溶である。
d-Solubility is easily soluble in dimethylnulphoxide and pyridine.
Soluble in methanol and water, insoluble in acetone, chloroform, ether and hexane.

e、薄層クロマトグラフィーC担体ニブレコードのノリ
力ゲル60F−254,0,25nttn、メルク社製
;展開溶媒:クロロホルム:メタノール:水−6:4:
1)に付した場合6つのRE値を示す。
e, thin layer chromatography C carrier Nibrecord Noriyoku Gel 60F-254, 0,25 nttn, manufactured by Merck &Co.; developing solvent: chloroform: methanol: water - 6:4:
1) indicates six RE values.

薄層クロマトグラム上1%硫酸第二セリウムとlO係硫
酸の混合液を噴霧し、加熱ずろと赤紫色を呈す。
Thin layer chromatogram shows that when a mixture of 1% ceric sulfate and 10% sulfuric acid is sprayed, it shows a reddish-purple color as it heats up.

実施例1 つきの処方により、常法に従ってクリーノ、を製造した
Example 1 Cleano was produced according to the following recipe according to a conventional method.

クリーム処方 成分       iTi: ;−,7%ヌテアリン酸
              10ヌテアリルアルコー
ル          4ステアリン酸ブチル    
        8乳化剤             
    2プロピレングリコール         】
Oグリセリン              4水酸化カ
リウム              0,4アズキザボ
ニン(参考例1のもの)0.1保存剤、着香剤    
         0.2精製水          
     残 部得られたクリーム5gをシヘ1−レに
とり、平らにのはして48時間紫外線照射を行なった。
Cream formulation ingredients iTi: ;-, 7% nutearic acid 10 nutaryl alcohol 4 butyl stearate
8 Emulsifier
2 Propylene Glycol]
O Glycerin Potassium 4 hydroxide 0.4 Azukizabonin (from Reference Example 1) 0.1 Preservative, flavoring agent
0.2 Purified water
5 g of the remaining cream was placed on a plate, spread flat, and irradiated with ultraviolet rays for 48 hours.

同様に、実施例1の処方からアズキザボニンを除いてク
リームを製造しく対照クリーム)、同様に紫外線照射を
行なった。これらの過酸化脂質量を八木法により測定し
た(測定値はTBA (チオバルビッール酸)値で表わ
す)。ついて、18〜52才の女性19人を対象とし、
まず、対照クリームにより、ついて、1力月後、同一対
象に対して実施例1のクリームで、各々、24時間のパ
ンチテストを行なった。結果を第1表に示す。
Similarly, a cream was prepared by removing Azukizabonin from the formulation of Example 1 (control cream) and was similarly irradiated with ultraviolet rays. The amounts of these lipid peroxides were measured by the Yagi method (measured values are expressed as TBA (thiobarbic acid) values). Then, 19 women aged 18 to 52 were targeted.
First, the control cream was applied, and after one month, a 24-hour punch test was conducted on the same subject using the cream of Example 1. The results are shown in Table 1.

第1表 注〕製造直後の’rBA値はいずれも8n −rno 
I/7第1表に示すとおり、アズキザボニンを配合した
実施例1のクリームは過酸化脂質増加による皮膚障害を
抑制する。
Table 1 Note: All 'rBA values immediately after manufacture are 8n-rno
As shown in Table 1 of I/7, the cream of Example 1 containing adzukizabonin suppresses skin damage caused by an increase in lipid peroxide.

実施例2 つきの処方により、常法に従って化粧石鹸を製造 しブ
こ。
Example 2 Cosmetic soap was manufactured according to the conventional method using the following formula.

化粧石鹸処方 成分       山(蒔 石鹸用素地             98.60アズ
キサボニン            0.05エチレン
ジアミン四酢酸ニナトリウム  0.20酸化チタン 
              0.15香料     
            1.00得られた化粧石鹸の
「肌あれ」、(−かぷれ」、「しみ」に対する効果をつ
きのとおりテストした。
Toilet soap prescription ingredients Yama (Maki soap base 98.60 Azuki sabonin 0.05 Disodium ethylenediaminetetraacetate 0.20 Titanium oxide
0.15 fragrance
1.00 The effect of the obtained cosmetic soap on "rough skin", (-bleeding), and "stains" was tested as usual.

対象二男子7名C7〜51才)、女子15名C23〜5
5才)。それぞれ、就寝前と起床時に温湯を用いて該化
粧石鹸で洗顔させた。なお、女子については、テスト前
後を通して使用比相[品、化粧法を変えないことを条件
とした。
Target 2: 7 boys (C7-51 years old), 15 girls (C23-5)
5 years old). Each subject washed their face with the cosmetic soap using warm water before going to bed and upon waking up. For girls, the condition was that they did not change the proportions [products and makeup methods] they used before and after the test.

評価:第2表に示す基準に従った。Evaluation: According to the criteria shown in Table 2.

第2表 評価:1→2、l→3.2→3の改善を有効とし、変化
なしまたは悪化を無効とした。なお、症状は単独の場合
も、他の症状を伴なう場合もあったが、各々、症状別に
評価した。
Evaluation in Table 2: Improvements from 1 to 2, 1 to 3.2 to 3 were considered valid, and no change or deterioration was considered invalid. In addition, the symptoms were evaluated individually, either alone or accompanied by other symptoms.

結果:第3表に示すとおり。Results: As shown in Table 3.

第3表 以上記載したこさく、アズキザボニン配合の化粧料は皮
膚障害の主因をなす過酸化脂質の影響を抑制し、皮膚症
状の改善にきわめてずくれた効果を特徴する
Cosmetics containing Kosaku and Azukizabonin listed in Table 3 and above suppress the effects of lipid peroxide, which is the main cause of skin disorders, and are characterized by extremely effective effects in improving skin symptoms.

Claims (1)

【特許請求の範囲】[Claims] (1)有効成分として、アズキサポニンを配合したこと
を特徴とする化粧料組成物。
(1) A cosmetic composition characterized by containing adzuki bean saponin as an active ingredient.
JP12245082A 1982-07-13 1982-07-13 Cosmetic composition containing adzuki saponin Pending JPS5913707A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP12245082A JPS5913707A (en) 1982-07-13 1982-07-13 Cosmetic composition containing adzuki saponin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12245082A JPS5913707A (en) 1982-07-13 1982-07-13 Cosmetic composition containing adzuki saponin

Publications (1)

Publication Number Publication Date
JPS5913707A true JPS5913707A (en) 1984-01-24

Family

ID=14836140

Family Applications (1)

Application Number Title Priority Date Filing Date
JP12245082A Pending JPS5913707A (en) 1982-07-13 1982-07-13 Cosmetic composition containing adzuki saponin

Country Status (1)

Country Link
JP (1) JPS5913707A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60184600A (en) * 1984-02-29 1985-09-20 小番 セツ Stain remover and use
JP2001131047A (en) * 1999-11-04 2001-05-15 Rasheru Seiyaku Kk Red bean extract-containing cosmetic composition
US11865202B2 (en) * 2011-12-19 2024-01-09 Mary Kay Inc. Combination of plant extracts to improve skin tone

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60184600A (en) * 1984-02-29 1985-09-20 小番 セツ Stain remover and use
JP2001131047A (en) * 1999-11-04 2001-05-15 Rasheru Seiyaku Kk Red bean extract-containing cosmetic composition
US11865202B2 (en) * 2011-12-19 2024-01-09 Mary Kay Inc. Combination of plant extracts to improve skin tone

Similar Documents

Publication Publication Date Title
JP2003113068A (en) Skin cosmetic
JP6005900B2 (en) Melanin production inhibitor and medicinal product, food or cosmetic having melanin production inhibitory action
JP2005213178A (en) TNF-alpha PRODUCTION INHIBITOR, ESTROGENIC AGENT AND EXTERNAL PREPARATION FOR SKIN
JP2001507712A (en) Use of Shogaols and Gingerols in the Production of Deodorizing Compositions
TWI436787B (en) Glutathione production enhancers and pharmaceuticals, foods or cosmetics that promote the production of glutathione
KR100530843B1 (en) Anti-inflammatory composition containing paecilomyces extract and cordyceps extracts as effective composition
JPS5913707A (en) Cosmetic composition containing adzuki saponin
JP2003160497A (en) Skin care preparation
WO2018225718A1 (en) Agent for inhibiting skin trouble and composition for inhibiting skin trouble
JP3170700B2 (en) Cosmetic for preventing skin aging
JP3828163B2 (en) Anti-inflammatory, anti-itch agent
JPH0314283B2 (en)
JP2000239145A (en) Anti-allergic agent, beautifully whitening agent and skin cosmetic
JP4579550B2 (en) Ceramide synthesis accelerator and external preparation for skin
KR100525722B1 (en) Topical constituents of ginsenoside Rh2 and ginsenoside Rg3
JP6723979B2 (en) Wrinkle improver
JP3432596B2 (en) Hair restorer
JP5649995B2 (en) Ceramide production promoter
JP2000212058A (en) Skin cosmetic, active oxygen eliminator, esterase inhibitor, and collagenase inhibitor
JP2017178862A (en) Anti-inflammatory agents, cosmetics, external skin agents, agents for ameliorating inflammatory disease, and methods for producing anti-inflammatory agents
JP5132030B2 (en) Immunostimulants, antitumor agents, anti-inflammatory agents, anti-aging agents and skin cosmetics
JP2001131079A (en) Skin preparation for external use
JPH0881337A (en) Hair tonic
JP2002053477A (en) Skin care preparation
JPS61254510A (en) External agent for skin